scispace - formally typeset
B

Beata Pajak

Researcher at Polish Academy of Sciences

Publications -  44
Citations -  6245

Beata Pajak is an academic researcher from Polish Academy of Sciences. The author has contributed to research in topics: Apoptosis & Programmed cell death. The author has an hindex of 16, co-authored 40 publications receiving 5621 citations. Previous affiliations of Beata Pajak include Warsaw University of Life Sciences.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents.

TL;DR: Attempts to improve 2-DG’s drug-like properties, its role as a potential adjuvant for other chemotherapeutics, and novel 2- DG analogs as promising new anticancer agents are discussed in this review.
Journal ArticleDOI

Molecular basis of parthenolide-dependent proapoptotic activity in cancer cells.

TL;DR: Unique properties of PN make this agent a promising metabolic inhibitor to retard tumorigenesis and to suppress tumor growth and advances in molecular biology indicate that this sesquiterpene lactone might evoke the above-mentioned effects by indirect action on genes.
Journal Article

Molecular basis of sodium butyrate-dependent proapoptotic activity in cancer cells.

TL;DR: Unique properties of NaBt make this agent a promising metabolic inhibitor to retard tumorigenesis to suppress tumor growth and to ampify the apoptotic signals.

Molecular basis of sodium butyrate-dependent proapoptotic activity in cancer cells. Adv Med Sci

TL;DR: In this paper, a review outlines the molecular events that accompany the antitumor action of sodium butyrate (NaBt), including higher expression of membrane death receptors (DR4/5), higher level and activation of Smad3 protein in TGF-beta-dependent apoptotic pathway, lower level of anti-apoptotic proteins (cFLIP, XIAP) and activations of Proap-optotic tBid protein.